These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33410421)

  • 1. The need to develop a framework for human-relevant research in India: Towards better disease models and drug discovery.
    Parvatam S; Bharadwaj S; Radha V; Rao M
    J Biosci; 2020; 45():. PubMed ID: 33410421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System.
    Hunsberger JG; Efthymiou AG; Malik N; Behl M; Mead IL; Zeng X; Simeonov A; Rao M
    Stem Cells Dev; 2015 Aug; 24(16):1852-64. PubMed ID: 25794298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons.
    Engle SJ; Blaha L; Kleiman RJ
    Neuron; 2018 Nov; 100(4):783-797. PubMed ID: 30465765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a national strategy to enable human-relevant research in India: A multistakeholder roundtable meeting report.
    Parvatam S
    ALTEX; 2022; 39(1):151-153. PubMed ID: 35034132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening out irrelevant cell-based models of disease.
    Horvath P; Aulner N; Bickle M; Davies AM; Nery ED; Ebner D; Montoya MC; Östling P; Pietiäinen V; Price LS; Shorte SL; Turcatti G; von Schantz C; Carragher NO
    Nat Rev Drug Discov; 2016 Nov; 15(11):751-769. PubMed ID: 27616293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realizing the potential of organoids-an interview with Hans Clevers.
    Bartfeld S
    J Mol Med (Berl); 2021 Apr; 99(4):443-447. PubMed ID: 33464358
    [No Abstract]   [Full Text] [Related]  

  • 9. Patient-derived induced pluripotent stem cells in cancer research and precision oncology.
    Papapetrou EP
    Nat Med; 2016 Dec; 22(12):1392-1401. PubMed ID: 27923030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can stem-cell-derived models revolutionize drug discovery?
    Landgren H; Sartipy P
    Expert Opin Drug Discov; 2014 Jan; 9(1):9-13. PubMed ID: 24308376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
    Costamagna G; Comi GP; Corti S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of induced pluripotent stem cells in drug development.
    Inoue H; Yamanaka S
    Clin Pharmacol Ther; 2011 May; 89(5):655-61. PubMed ID: 21430656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How induced pluripotent stem cells are informing drug discovery in psychiatry.
    Sun Y; Dolmetsch RE
    Swiss Med Wkly; 2016; 146():w14241. PubMed ID: 26752334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson's Disease for Drug Identification.
    Kouroupi G; Antoniou N; Prodromidou K; Taoufik E; Matsas R
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Optical Approaches with Human Inducible Pluripotent Stem Cells in G Protein-Coupled Receptor Drug Screening and Development.
    Bourque K; Jones-Tabah J; Mnasri N; Martin RD; Hébert TE
    Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30567417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research on early mammalian development in India.
    Seshagiri PB; Vani V
    Int J Dev Biol; 2020; 64(1-2-3):109-121. PubMed ID: 32658999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One Step Into the Future: New iPSC Tools to Advance Research in Parkinson's Disease and Neurological Disorders.
    Mohamed NV; Larroquette F; Beitel LK; Fon EA; Durcan TM
    J Parkinsons Dis; 2019; 9(2):265-281. PubMed ID: 30741685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.
    Abi-Gerges N; Miller PE; Ghetti A
    Curr Pharm Biotechnol; 2020; 21(9):787-806. PubMed ID: 31820682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.